Advertisement

 

 

U.S. High-Level Isolation Unit Clinical Laboratory Capabilities Update.

U.S. High-Level Isolation Unit Clinical Laboratory Capabilities Update.
Author Information (click to view)

Herstein JJ, Iwen PC, Jelden KC, Biddinger PD, Gibbs SG, Le AB, Hewlett A, Lowe JJ,


Herstein JJ, Iwen PC, Jelden KC, Biddinger PD, Gibbs SG, Le AB, Hewlett A, Lowe JJ, (click to view)

Herstein JJ, Iwen PC, Jelden KC, Biddinger PD, Gibbs SG, Le AB, Hewlett A, Lowe JJ,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Journal of clinical microbiology 2017 11 22() pii JCM.01608-17
Abstract

In late 2014, fifty-six hospitals in the US were designated by state and federal public health authorities as specially-designed high-level isolation units (HLIUs) equipped with advanced infrastructure, laboratory capabilities, and trained staff to care for patients with highly hazardous communicable diseases (HHCDs), such as Ebola. This survey describes clinical laboratory support capabilities of U.S. HLIUs, including the specific test menus that HLIUs have identified to safely manage HHCD patients, and the locations where such testing would be performed. In spring 2016, a survey was electronically distributed as a fillable PDF to the 56 US HLIUs. Site representatives completed surveys and data were coded and analyzed in an electronic spreadsheet using descriptive statistics. Thirty-six (64%) HLIUs responded; 33 completed the laboratory capabilities section. Thirty-one (94%) HLIUs had performed risk analyses for all laboratory procedures and equipment. Twenty-nine (88%) had decontamination procedures specified for all laboratory equipment used for suspected or confirmed HHCD patients. Onsite laboratories in 27 (81%) HLIUs had the capacity to inventory and securely store HHCD patient specimens. Ten (31%) HLIUs had at least one test they would conduct within the patient isolation room. The high-risk nature of HHCDs and potential occupational exposures that can occur in clinical laboratories demands advanced preparation and risk assessment by HLIU laboratories of work practices, laboratory equipment, and instrumentation. Although risk analyses that HLIUs have conducted on clinical laboratory testing and equipment are likely focused on those for Ebola virus, HLIUs must be prepared to revise their current procedures for other HHCDs.

Submit a Comment

Your email address will not be published. Required fields are marked *

3 − 2 =

[ HIDE/SHOW ]